Anticorps monoclonal anti-IL-1R1 thérapeutique

• 收藏
• 分享

专利权人:

AMGEN INC.;MEDAREX, INC.

发明人:

申请号：

EP10003365.3

公开号：

EP2213685B1

申请日:

2003.09.05

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

Antibodies that interact with interleukin-1 receptor type 1 (IL-1R1) are described. Methods of treating IL-1 mediated diseases by administering a pharmaceutically effective amount of antibodies to IL-1R1 are described. Methods of detecting the amount of IL-1R1 in a sample using antibodies to IL-1R1 are described.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/